Health & Biotech
Check out the latest Drug Development news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Health Check: Prestigious publication supports Alterity’s ‘iron overload in brain’ thesis
Health & Biotech
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Health & Biotech
‘Breakthrough’ quarter for Island Pharmaceuticals
Health & Biotech
Health Check: PharmX has 99pc share of pharmacy market but reckons it has prescription for growth
Health & Biotech
Biocurious: Invion taps the power of light to zap solid tumours
Health & Biotech
Key findings could boost Dimerix’s rare kidney disease drug trial
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
Health & Biotech
Health Check: Approval clock ticks as FDA accepts Telix’s brain diagnostic marketing application
Health & Biotech
Health Check: Despite headwinds, Australia’s third force in pharmacy finds prescription for growth
Health & Biotech
Biocurious: Cracking the code on Paradigm’s valuation enigma
Health & Biotech
Health Check: Latest biotech quarterly results are as patchy as the curate’s egg
Health & Biotech
Health Check: Just the news we ‘kneed’ as Paradigm aims to kick-start US osteo trial
Health & Biotech
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
Health Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitability
Health & Biotech
Health Check: Fresh from its FDA win, Echo IQ aims for even bigger heart failure approval
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
Health & Biotech
Health Check: Long-suffering Mesoblast investors dare to dream
Health & Biotech
Island lifts 50pc on $3.5m capital raise and Phase 2a/b dengue trial progress
Health & Biotech
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
Health & Biotech
Health Check: Farewell, adieu as Argent Biopharma holders back ASX delisting
Health & Biotech
Health Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging deal
Health & Biotech
Health Check: The Winner Takes It All as US investors back advanced biotech plays
Health & Biotech
Health Check: Cancer drug developer Chimeric heads to blood bank for better patient cells
Health & Biotech
Paradigm steps closer to Phase 3 trial for knee arthritis treatment after FDA feedback
Health & Biotech
‘Holy Grail’ – Alterity Therapeutics aims to slow progression of Parkinson’s disease
Health & Biotech
Dimerix enters key collaboration to further boost ACTION3 trial recruitment in UK
Health & Biotech
Key paediatric milestone reached in Dimerix’s kidney-disease drug trial
Health & Biotech
Dimerix first patient completes Phase 3 trial and enters into long-term DMX-200 Open Label Extension study
Health & Biotech
Neurotech’s cannabinoid drug reverses immune dysregulation in PANDAS/PANS kids
Health & Biotech
Neurotech chases another orphan drug designation
Health & Biotech
Race Oncology races ahead in FY24 with key milestones
Health & Biotech
LTP enters deal with Aptar Pharma to develop Spontan nasal spray
Health & Biotech
Neurotech focuses on global partnerships and Aussie registration
Stockhead TV
Break it Down: LTR Pharma prescribes ED spray under TGA scheme
Health & Biotech
Patients uplifted by LTR Pharma’s ED treatment Spontan under TGA scheme
Stockhead TV
Long Shortz with Race Oncology: Study proves effective for Acute myeloid leukaemia drug
Health & Biotech
Neurotech’s Rett Syndrome trial shows improvement in extension stage
Health & Biotech
Race Oncology’s lead drug AML study successfully concludes
Health & Biotech
LTR Pharma raises $10.5m to advance erectile dysfunction treatment SPONTAN
Health & Biotech
Neurotech Phase 2/3 autism trial shows uplift in mood while lowering anxiety and depression
Health & Biotech
Neurotech reports further positive Phase 2/3 autism trial results
Health & Biotech
Neurotech chasing prized US orphan drug designation
Load More